Phathom Pharmaceuticals (PHAT) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$138.0 million.
- Phathom Pharmaceuticals' Enterprise Value rose 5911.06% to -$138.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$138.0 million, marking a year-over-year increase of 5911.06%. This contributed to the annual value of -$300.1 million for FY2024, which is 2189.45% up from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Enterprise Value is -$138.0 million, which was up 5911.06% from -$152.4 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Enterprise Value ranged from a high of -$130.1 million in Q1 2023 and a low of -$384.3 million during Q4 2023
- Over the past 4 years, Phathom Pharmaceuticals' median Enterprise Value value was -$215.2 million (recorded in 2025), while the average stood at -$228.5 million.
- Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 14992.2% in 2024, then skyrocketed by 5911.06% in 2025.
- Phathom Pharmaceuticals' Enterprise Value (Quarter) stood at -$155.9 million in 2022, then tumbled by 146.49% to -$384.3 million in 2023, then increased by 21.89% to -$300.1 million in 2024, then soared by 54.01% to -$138.0 million in 2025.
- Its Enterprise Value was -$138.0 million in Q3 2025, compared to -$152.4 million in Q2 2025 and -$215.2 million in Q1 2025.